LEO PHARMA A/S: Financial statements 2015
CVR: 56759514
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
LEO PHARMA A/S (CVR 56759514) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 6,876,000,000 and a net result of DKK 645,000,000 compared with DKK 1,544,000,000 the year before. That is an increase of 4.6% compared with the year before. The profit margin was 9.4%. Equity in the 2015 report amounted to DKK 25,282,000,000. The solvency ratio was 71%. The company had 4,813 employees in the financial year.
- Revenue
- DKK 6,876,000,000
- Gross Profit
- DKK 2,038,000,000
- Profit/Loss
- DKK 645,000,000
- Equity
- DKK 25,282,000,000
- Total Assets
- DKK 35,603,000,000
- Employees
- 4,813
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 6.9 mia. | 2 mia. | 645 mio. | 25.3 mia. | 4813 |
| 2014 | 6.6 mia. | - | 1.5 mia. | 24.5 mia. | 4712 |
| 2013 | 5.8 mia. | - | 1.2 mia. | 23.1 mia. | 4733 |
Official annual report
How creditworthy is LEO PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of December 31, 2015, Jukka Pekka Pertola has left the board of directors of LEO PHARMA A/S.
As of December 31, 2015, Patrik Olof Dahlén has left the board of directors of LEO PHARMA A/S.
As of December 31, 2015, Lars Olsen has stepped down as director of LEO PHARMA A/S.
As of October 1, 2015, Anders Kronborg is registered as director of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2014. Revenue came to DKK 6,571,000,000, and the net result was DKK 1,544,000,000.
As of April 21, 2015, Jukka Pekka Pertola has joined the board of directors of LEO PHARMA A/S.
As of April 21, 2015, Patrik Olof Dahlén has joined the board of directors of LEO PHARMA A/S.
As of April 20, 2015, Jukka Pekka Pertola has left the board of directors of LEO PHARMA A/S.
About LEO PHARMA A/S
LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Christophe Dominique Luc Charles Bourdon and Philip Harald Eickhoff. The board consists of Jesper Brandgaard (chair), Paul Olivier Marie Navarre, Peter Helt Jacobsen Haahr and Aino Anna Liisa Hurme. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 1,047 employees (2026). In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity in the 2025 report amounted to DKK 5,262,000,000.